| Literature DB >> 30791512 |
Christian Gerlinger1,2, Michael Oster3, Luisa Borgelt4, Henry Reyer5, Eduard Muráni6, Siriluck Ponsuksili7, Christian Polley8, Brigitte Vollmar9, Martin Reichel10, Petra Wolf11, Klaus Wimmers12,13.
Abstract
Phosphorus (P) is an important element of various metabolic and signalling processes, including bone metabolism and immune function. To elucidate the routes of P homeostasis and utilization, a five-week feeding study was conducted with weaned piglets receiving a diet with recommended amounts of P and Ca (M), or a diet with lower (L) or higher (H) P values and a constant Ca:P ratio. Routes of P utilization were deduced via bone characteristics (MicroCT), genome-wide transcriptomic profiles of peripheral blood mononuclear cells (PBMCs), and serum mineral levels. MicroCT revealed significantly lower bone mineral density, trabecular number, and mechanical fracture load in (L). Gene expression analyses showed transcripts of 276 and 115 annotated genes with higher or lower abundance in (H) than (L) that were related to basic cellular and metabolic processes as well as response to stimuli, developmental processes and immune system processes. This study shows the many molecular routes involved in P homeostasis that should be considered to improve endogenous mechanisms of P utilization.Entities:
Keywords: calcium homeostasis; dietary mineral intake; immunomodulation; phosphorus homeostasis; trabecular bone
Mesh:
Substances:
Year: 2019 PMID: 30791512 PMCID: PMC6412343 DOI: 10.3390/nu11020436
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Representative images obtained from micro-CT analyses of porcine femurs. (A). The volume of interest (VOI) was set distal to the hip joint at 30% of the total femur length (yellow line) and covered 800 slices (light blue lines). (B). Region of interest (ROI) (red) represents the trabecular bone for measurements of bone mineral density (BMD). (C). ROI (red) to approximate the tissue mineral density (TMD) in cortical bone.
Figure 2Daily weight gain and feed intake of piglets fed variable dietary amounts of P and Ca. Data refer to the weekly means of body weight gain and feed intake throughout the feeding trial (details are displayed in Table S2). Low P diet (white bars); Medium (recommended) P diet (gray bars); High P diet (black bars); * p < 0.05.
Densiometric and morphometric characteristics of femurs excised from 64-day-old piglets fed variable dietary amounts of P and Ca.
| L | M | H | |||||
|---|---|---|---|---|---|---|---|
| Item | Unit | Mean | SD | Mean | SD | Mean | SD |
| Tissue mineral density (TMD) | g/mm3 | 1.06 | 0.03 | 1.07 | 0.04 | 1.10 | 0.02 |
| Bone mineral density (BMD) | g/mm3 | 0.08 a | 0.02 | 0.16 b | 0.03 | 0.15 b | 0.04 |
| Bone volume/Total volume (BV/TV) | % | 16.68 a | 3.69 | 25.31 b | 6.05 | 23.80 b | 5.22 |
| Structural model index (SMI) | 1.09 | 0.19 | 1.20 | 0.73 | 1.23 | 0.49 | |
| Trabecular number (TbN) | 1/mm | 0.94 a | 0.19 | 1.39 b | 0.21 | 1.23 a,b | 0.49 |
| Trabecular separation (TbSp) | mm | 3.44 b | 1.87 | 0.95 a | 0.51 | 1.13 a | 1.03 |
| Trabecular thickness (TbTh) | mm | 0.18 | 0.01 | 0.18 | 0.02 | 0.31 | 0.33 |
| Fracture load | N | 764.9 a | 110.9 | 999.9 b | 153.2 | 920.4 b | 208.2 |
| Maximum deflection | mm | 6.5 b | 2.0 | 4.6 a | 1.1 | 4.1 a | 0.7 |
a,b Indicate significant differences between groups (p < 0.05). L—Low P diet; M—Medium P diet; H—High P diet; SD—Standard Deviation.
Figure 3Serum inorganic P, Ca, Zn, and Cu levels of pigs fed variable dietary amounts of P and Ca. Values for serum inorganic P and Ca were obtained previously [17]. L—Low P diet; M—Medium (recommended) P diet; H—High P diet; * p < 0.05.
Excerpt of pathways altered in PBMC of piglets fed diets with low and high amounts of P and Ca. Pathways were selected for affiliation with immune response, biosynthesis, and signaling. A full list of pathways is displayed in Table S4.
| Pathway Name | Responsive Transcripts | |
|---|---|---|
|
| ||
| Superpathway of Inositol Phosphate Compounds * | - |
|
| EIF2 Signaling * | 1.13 |
|
| CDP-diacylglycerol Biosynthesis I † | - |
|
| Triacylglycerol Biosynthesis † | - |
|
| Interferon Signaling * | 2.00 |
|
|
| ||
| IL-10 Signaling ‡ | - |
|
| IL-6 Signaling ‡ | 2.89 |
|
| Acute Phase Response Signaling ‡ | 2.11 |
|
| NF-κB Signaling † | 3.05 |
|
| Th1 and Th2 Activation Pathway † | - |
|
| T Helper Cell Differentiation † | - |
|
| Th1 Pathway * | 1.41 |
|
| Fcγ Receptor mediated Phagocytosis in Macrophages and Monocytes † | 2.12 |
|
| Granulocyte Adhesion and Diapedesis † | - |
|
| Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses * | 2.00 |
|
| LXR/RXR Activation ‡ | 2.53 |
|
| LPS/IL-1 Mediated Inhibition of RXR Function † | 1.89 |
|
| PPAR Signaling * | 2.65 |
|
|
| ||
| RhoA Signaling * | 0.38 |
|
| p38 MAPK Signaling † | 2.83 |
|
| TREM1 Signaling * | 2.45 |
|
| iNOS Signaling * | 2.24 |
|
The significance of association between the data set and pathway: * p < 0.05; † p < 0.01; ‡ p < 0.001. Positive and negative z-scores suggest activation or inhibition, respectively. Missing z-scores have not been calculated due to lack of database information. Gene symbols in bold font: H > L; gene symbols in normal font: H < L. EIF—Eukaryotic initiation factor, CDP—Cytidine diphosphate, IL—Interleukin, NF-κB—Nuclear factor κB, Th—T helper cell, LXR—Liver X receptor, RXR—Retinoid X receptor, LPS—Lipopolysaccharide, PPAR—Peroxisome proliferator-activated receptors, RhoA—Ras homolog gene family, member A, MAPK—Mitogen-activated protein kinase, TREM1—Triggering receptor expressed on myeloid cells 1, iNOS—Inducible nitric oxide synthase.
Transcripts showing the highest differences in mRNA abundance between animals fed the L and H diets.
| Gene Symbol | FC 1 | Function | ||
|---|---|---|---|---|
|
| 5.95 | <0.001 | 0.075 | cytokine receptor |
|
| 3.55 | <0.001 | 0.102 | transmembrane protein/ligase |
|
| 3.40 | <0.001 | 0.087 | arginine metabolism |
|
| 3.22 | 0.001 | 0.123 | G-protein coupled receptor |
|
| 3.14 | 0.002 | 0.144 | interleukin receptor |
|
| −3.81 | <0.001 | 0.102 | sphingolipid biosynthesis |
|
| −2.09 | 0.003 | 0.151 | membrane glycoprotein |
|
| −1.84 | 0.007 | 0.186 | elongation factor |
|
| −1.81 | 0.009 | 0.201 | binding protein |
|
| −1.74 | 0.003 | 0.151 | endonuclease |
1 Fold change; positive FC (L < H); negative FC (L > H); IL22RA2—Interleukin 22 receptor subunit alpha 2; RNF128—ring finger protein 128, E3 ubiquitin protein ligase; ARG2—arginase 2; C3AR1—complement C3a receptor 1; IL1R2—interleukin 1 receptor type 2; SPTSSA—serine palmitoyltransferase small subunit A; PLPP3—phospholipid phosphatase 3; EEF1A1—eukaryotic translation elongation factor 1 alpha 1; PEBP1—phosphatidylethanolamine binding protein 1; APEX1—apurinic/apyrimidinic endodeoxyribonuclease 1.
Figure 4Gene Ontology (GO)-terms. Results refer to genes differentially expressed in animals fed the L and H diets. The analysis shows significantly enriched terms for (A) molecular functions and (B) biological processes.